Posted inGenral
FDA Signals Enforcement Action Against Non-Approved GLP-1
The FDA has recently signaled its intention to take enforcement actions against non-approved GLP-1 (glucagon-like peptide-1) receptor agonists, following concerns about the safety and efficacy of these products. GLP-1 medications…











